Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary malignant pericardial mesothelioma with difficult antemortem diagnosis: A case report. | World J Clin Cases | 2022 | 36483836 | PubTator, text mining | PubMed |
Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma. | Front Immunol | 2022 | 36483553 | PubTator, text mining | PubMed |
| Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy. | Front Immunol | 2022 | 36479115 | PubTator, text mining | PubMed |
| Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing. | J Transl Med | 2022 | 36474268 | PubTator, text mining | PubMed |
| LY6D marks pre-existing resistant basosquamous tumor subpopulations. | Nat Commun | 2022 | 36473848 | PubTator, text mining | PubMed |
| Undifferentiated Pleomorphic Sarcoma Presenting With Cardiac Tamponade: A Case Report and Review. | J Investig Med High Impact Case Rep | 2022 | 36458807 | PubTator, text mining | PubMed |
| Advanced development and mechanism of sepsis-related acute respiratory distress syndrome. | Front Med (Lausanne) | 2022 | 36452899 | PubTator, text mining | PubMed |
| Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure. | Front Oncol | 2022 | 36452500 | PubTator, text mining | PubMed |
| Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants. | Clin Exp Vaccine Res | 2022 | 36451668 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma. | Cell Rep | 2022 | 36450256 | PubTator, text mining | PubMed |
| SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics. | Cureus | 2022 | 36439610 | PubTator, text mining | PubMed |
| Mucosal delivery of nanovaccine strategy against COVID-19 and its variants. | Acta Pharm Sin B | 2022 | 36438851 | PubTator, text mining | PubMed |
| Ferulic acid alleviates alveolar epithelial barrier dysfunction in sepsis-induced acute lung injury by activating the Nrf2/HO-1 pathway and inhibiting ferroptosis. | Pharm Biol | 2022 | 36433644 | PubTator, text mining | PubMed |
| Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers. | J Clin Med | 2022 | 36431263 | PubTator, text mining | PubMed |
| Computational Tactics for Precision Cancer Network Biology. | Int J Mol Sci | 2022 | 36430875 | PubTator, text mining | PubMed |
| Molecular Indicators of Blood-Brain Barrier Breakdown and Neuronal Injury in Pregnancy Complicated by Fetal Growth Restriction. | Int J Mol Sci | 2022 | 36430274 | PubTator, text mining | PubMed |
| Near Missed Case of Occupational Pleural Malignant Mesothelioma, a Case Report and Latest Therapeutic Options. | Int J Environ Res Public Health | 2022 | 36429481 | PubTator, text mining | PubMed |
| Claudin-10 Expression Is Increased in Endometriosis and Adenomyosis and Mislocalized in Ectopic Endometriosis. | Diagnostics (Basel) | 2022 | 36428908 | PubTator, text mining | PubMed |
| Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics. | RSC Adv | 2022 | 36425155 | PubTator, text mining | PubMed |
| A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection. | Sci Rep | 2022 | 36424447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=35